PolyPeptide Group AG (PPGN) — Cash Flow Reinvestment Rate
PolyPeptide Group AG (PPGN) has a Cash Flow Reinvestment Rate of 0.98x as of June 2025, reinvesting CHF48.68 Million (capex CHF48.68 Million ) from operating cash flow of CHF49.66 Million. Check PPGN cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
PolyPeptide Group AG Cash Flow Reinvestment Rate (2018–2024)
Historical reinvestment intensity for PolyPeptide Group AG across 7 annual periods. Explore PolyPeptide Group AG cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for PolyPeptide Group AG (2018–2024)
Year-by-year capital reinvestment analysis for PolyPeptide Group AG. For live market cap and broader valuation context, see PPGN company net worth.
| Year | Reinvestment Rate | Total Reinvested (CHF) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.99x | CHF177.99 Million | CHF89.40 Million | CHF86.97 Million | ▼ -37.5% |
| 2023 | 3.19x | CHF116.25 Million | CHF36.48 Million | CHF56.73 Million | ▼ -88.9% |
| 2022 | 28.79x | CHF157.20 Million | CHF5.46 Million | CHF78.76 Million | ▲ +1939.4% |
| 2021 | 1.41x | CHF80.97 Million | CHF57.35 Million | CHF77.71 Million | ▲ +70.9% |
| 2020 | 0.83x | CHF40.88 Million | CHF49.48 Million | CHF40.62 Million | ▲ +102.3% |
| 2019 | 0.41x | CHF22.70 Million | CHF55.60 Million | CHF19.70 Million | ▼ -49.6% |
| 2018 | 0.81x | CHF18.59 Million | CHF22.94 Million | CHF18.30 Million | — |